AAAAAA
Results: 376-400/1318
Authors:
DEGROOT MJA
Citation: Mja. Degroot, AGROBACTERIUM-TUMEFACIENS-MEDIATED TRANSFORMATION OF FILAMENTOUS FUNGI (VOL 16, PG 839, 1998), Nature biotechnology, 16(11), 1998, pp. 1074-1074
Authors:
HENZLER HJ
KAISER K
Citation: Hj. Henzler et K. Kaiser, AVOIDING VIRAL CONTAMINATION IN BIOTECHNOLOGICAL AND PHARMACEUTICAL PROCESSES, Nature biotechnology, 16(11), 1998, pp. 1077-1079
Authors:
PERSIDIS A
Citation: A. Persidis, SIGNAL-TRANSDUCTION AS A DRUG-DISCOVERY PLATFORM, Nature biotechnology, 16(11), 1998, pp. 1082-1083
Citation: WAR ON CANCER II, Nature biotechnology, 16(10), 1998, pp. 885-885
Citation: PHARMACOGENOMICS AT WORK, Nature biotechnology, 16(10), 1998, pp. 885-885
Authors:
MILLER H
Citation: H. Miller, REGULATION - NEW FDA APPOINTMENT OFFERS FOOD FOR THOUGHT, Nature biotechnology, 16(10), 1998, pp. 886-886
Authors:
HOYLE R
Citation: R. Hoyle, THERAPEUTICS - GENENTECH IS POISED FOR AN ANTICANCER BREAKTHROUGH, Nature biotechnology, 16(10), 1998, pp. 887-887
Authors:
GUPTA A
SILVER S
Citation: A. Gupta et S. Silver, MOLECULAR-GENETICS - SILVER AS A BIOCIDE - WILL RESISTANCE BECOME A PROBLEM, Nature biotechnology, 16(10), 1998, pp. 888-888
Authors:
RAMON D
CALVO MD
PERIS J
Citation: D. Ramon et al., NEW REGULATION FOR LABELING GENETICALLY-MODIFIED FOODS - A SOLUTION OR A PROBLEM, Nature biotechnology, 16(10), 1998, pp. 889-889
Authors:
DEKEYSER JL
Citation: Jl. Dekeyser, SKEWING THE NUMBERS, Nature biotechnology, 16(10), 1998, pp. 889-889
Authors:
DAVIDSON S
Citation: S. Davidson, INCYTE SNPS UP HEXAGEN FOR NEW FIRM, Nature biotechnology, 16(10), 1998, pp. 895-895
Authors:
HODGSON J
Citation: J. Hodgson, ICELAND CONSIDERS ITS GENETIC FUTURE, Nature biotechnology, 16(10), 1998, pp. 896-897
Authors:
HODGSON J
Citation: J. Hodgson, MILLENNIUM COLLABORATES WITH LEADING CLINICAL CENTERS, Nature biotechnology, 16(10), 1998, pp. 897-897
Authors:
SAEGUSA A
Citation: A. Saegusa, JAPANESE ABANDON DOMESTIC TRIALS, Nature biotechnology, 16(10), 1998, pp. 898-899
Authors:
DOREY E
Citation: E. Dorey, NEXSTAR SEEKS BETTER VALUATION THROUGH DISINTEGRATION, Nature biotechnology, 16(10), 1998, pp. 898-898
Authors:
GLASER V
Citation: V. Glaser, ANTIINFLAMMATORY INFLAMES CENTOCORS PROFITS, Nature biotechnology, 16(10), 1998, pp. 900-900
Authors:
FOX JL
Citation: Jl. Fox, FDA URGED TO COMPLY WITH 1997 REFORM ACT, Nature biotechnology, 16(10), 1998, pp. 901-902
Authors:
SWAN N
Citation: N. Swan, COSTS DRIVE ACCEPTANCE OF TRANSGENIC BIOASSAYS, Nature biotechnology, 16(10), 1998, pp. 902-903
Authors:
MICHAEL A
Citation: A. Michael, BIOTECH COMPANIES JUST CANT GET THE STAFF THESE DAYS, Nature biotechnology, 16(10), 1998, pp. 903-903
Authors:
DOVE A
Citation: A. Dove, ROSLIN FALSELY ACCUSED OF BIOPIRACY, Nature biotechnology, 16(10), 1998, pp. 904-904
Authors:
SALT DE
Citation: De. Salt, ARBOREAL ALCHEMY, Nature biotechnology, 16(10), 1998, pp. 905-905
Authors:
CATTERALL WA
Citation: Wa. Catterall, YEASTY BREW YIELDS NOVEL CALCIUM-CHANNEL INHIBITOR, Nature biotechnology, 16(10), 1998, pp. 906-906
Authors:
GOFFEAU A
Citation: A. Goffeau, GENOMIC-SCALE ANALYSIS GOES UPSTREAM, Nature biotechnology, 16(10), 1998, pp. 907-908
Authors:
CAPORALE LH
Citation: Lh. Caporale, LESSONS FROM THE MOST INNOVATIVE GENETIC ENGINEER, Nature biotechnology, 16(10), 1998, pp. 908-909
Authors:
HENDRICKSON W
Citation: W. Hendrickson, TEACHING AN OLD BUG NEW TRICKS, Nature biotechnology, 16(10), 1998, pp. 910-911